Canopy Growth Corp (WEED)

[Wo]

Extract selling licence is greatly anticipated by CGC board , clients and investors, although the product is expected to be heavily restricted and diluted.

Is it a fair assumption that more Dr's will be more willing to prescribe through the MMPR if they are able to prescribe extracts? A non smoking method?

Will that then help to increase the numbers of Dr's willing to prescribe and perhaps the numbers of patients with access, albeit heavily diluted THC?

Note: there is no limit on any other cannabinoid except THC. So the hundreds of others can be as extracted as potent as needed and prescribed. This will allow an emphasis on a variety of treatment options, other than the hallucinogenic effects of THC.

So I consider this move to be a solid win. With all the information that real double-blind research studies will produce, the benefits of all the other cannabinoids will be made evident. They may be the medicinal the shining stars. The Yureekas! There has been evidence that THC is as effective in small doses as much as high doses depending on method of application. So to focus on just 1 out hundreds seems misguided and underestimated.

So although MMPR is binder to 3% THC, doctors may readily prescribe 50% Cbd extracts for arthritis, inflammation, etcetera, whatever the evidence presents.

Let's not woe the steady developments.

As long as the trajectory is linear in way that will improve legitimacy , quality, and legally regulated access for all who need cannabis, in effective and harm reducing forms (medical or recreational), I suspect CGC will do very well.